Robert J. Glynn

Estimation and testing for clustered interval-censored bivariate survival data with application using the semi-parametric version of the Clayton-Oakes model.

Rosner B, Bay C, Glynn RJ, Ying GS, Maguire MG, Lee MT.

Lifetime Data Anal. 2023 Jan 20. PMID: 36670299

Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin.

Shin H, Schneeweiss S, Glynn RJ, Patorno E.

Ann Intern Med. 2022 12. 175(12):W155. PMID: 36534995

Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.

Solomon DH, Giles JT, Liao KP, Ridker PM, Rist PM, Glynn RJ, Broderick R, Lu F, Murray MT, Vanni K, Santacroce LM, Abohashem S, Robson PM, Fayad Z, Mani V, Tawakol A, Bathon J.

Ann Rheum Dis. 2022 Nov 30. PMID: 36450449

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.

Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM.

N Engl J Med. 2022 Nov 24. 387(21):1923-1934. PMID: 36342113

Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020.

Ko D, Lin KJ, Bessette LG, Lee SB, Walkey AJ, Cheng S, Kim E, Glynn RJ, Kim DH.

JAMA Netw Open. 2022 11 01. 5(11):e2242964. PMID: 36399339

Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes.

Zhuo M, D'Andrea E, Paik JM, Wexler DJ, Everett BM, Glynn RJ, Kim SC, Patorno E.

JAMA Netw Open. 2022 10 03. 5(10):e2235995. PMID: 36219443

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.

Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Kim SC, Najafzadeh M, Koeneman L, Farsani SF, Déruaz-Luyet A, Paik JM, Patorno E.

JAMA Netw Open. 2022 10 03. 5(10):e2237606. PMID: 36264574

Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.

Desai RJ, Glynn RJ, Everett BM, Schneeweiss S, Wexler DJ, Bessette LG, Déruaz-Luyet A, Vedin O, Brodovicz K, Patorno E.

Am Heart J. 2022 Dec. 254:203-215. PMID: 36150454

Effects of vitamin C supplementation on gout risk: results from the Physicians' Health Study II trial.

Juraschek SP, Gaziano JM, Glynn RJ, Gomelskaya N, Bubes VY, Buring JE, Shmerling RH, Sesso HD.

Am J Clin Nutr. 2022 09 02. 116(3):812-819. PMID: 35575611

Reply.

Halawa OA, Kolli A, Oh G, Mitchell WG, Glynn RJ, Kim DH, Friedman DS, Zebardast N.

Ophthalmology. 2022 Nov. 129(11):e155-e156. PMID: 36041954